116 A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer

✍ Scribed by K. Vallis; R. Reilley; D. Scollard; J. Petronis; C. Caldwell; A. Hendler; G. Lockwood; A. Oza

• Book ID: 119516817
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 122 KB
• Volume: 76
• Category: Article
• ISSN: 0167-8140
• DOI: 10.1016/s0167-8140(05)80277-4